Skip to content

Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning

Pilot Study - Assessing the Impact of Using a Neuromuscular Blocking Agent to Reduce Neuromuscular Junction Damage and Intermediate Syndrome in Organophosphorus (OP) Insecticide Poisoned Patients Requiring Ventilation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2014/018
Enrollment
45
Registered
2014-09-17
Start date
2014-05-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organophosphate poisoning

Interventions

Patients meeting inclusion/exclusion criteria will be randomized into three arms. The first arm will receive standard therapy alone (no rocuronium) The second arm will receive rocuronium bolus and

Sponsors

South Asian Clinical Toxicology Research Collaboration
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female 2. Age over 16 years 3. Clinical diagnosis of OP insecticide poisoning 4. Admission to Intensive Care Unit for ventilation 5. Informed consent from family 6. An initial Train-of-Four measurement (Neuromuscular junction function) of > 50% using standard anaesthetic neurophysiology equipment

Exclusion criteria

Exclusion criteria: 1. Failure to obtain informed consent from patient’s family 2. Age 16 years or younger 3. Patients who are pregnant 4. Patients will be removed from the study at their own or their family’s request

Design outcomes

Primary

MeasureTime frame
Number of days ventilated [On extubation]

Secondary

MeasureTime frame
Train of four measurement on repetitive nerve stimulation. [Every Ventillated day for a maximum of 5 days]

Countries

Sri Lanka

Contacts

Public ContactProfessor Indika Gawarammana

Principle investigator, Director South Asian Clinical Toxicology Research Collaboration

indika@sactrc.org0094-81-2384556

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026